WO2000053030A2 - Pet food product with coconut endosperm fibre - Google Patents
Pet food product with coconut endosperm fibre Download PDFInfo
- Publication number
- WO2000053030A2 WO2000053030A2 PCT/GB2000/000890 GB0000890W WO0053030A2 WO 2000053030 A2 WO2000053030 A2 WO 2000053030A2 GB 0000890 W GB0000890 W GB 0000890W WO 0053030 A2 WO0053030 A2 WO 0053030A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- coconut
- fibre
- food product
- pet food
- copra
- Prior art date
Links
- 244000060011 Cocos nucifera Species 0.000 title claims abstract description 208
- 235000013162 Cocos nucifera Nutrition 0.000 title claims abstract description 208
- 239000000835 fiber Substances 0.000 title claims abstract description 136
- 235000013305 food Nutrition 0.000 title claims abstract description 110
- 238000000034 method Methods 0.000 claims abstract description 80
- 241001465754 Metazoa Species 0.000 claims abstract description 64
- 238000004519 manufacturing process Methods 0.000 claims abstract description 57
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 29
- 210000002429 large intestine Anatomy 0.000 claims abstract description 21
- 230000001717 pathogenic effect Effects 0.000 claims abstract description 12
- 230000000968 intestinal effect Effects 0.000 claims abstract description 9
- 208000035143 Bacterial infection Diseases 0.000 claims abstract description 7
- 208000022362 bacterial infectious disease Diseases 0.000 claims abstract description 7
- 206010061218 Inflammation Diseases 0.000 claims abstract description 6
- 230000004054 inflammatory process Effects 0.000 claims abstract description 6
- 210000003608 fece Anatomy 0.000 claims description 65
- 230000036541 health Effects 0.000 claims description 23
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 15
- 241000282465 Canis Species 0.000 claims description 12
- 235000013312 flour Nutrition 0.000 claims description 12
- 239000004615 ingredient Substances 0.000 claims description 11
- 241000589876 Campylobacter Species 0.000 claims description 10
- 238000011282 treatment Methods 0.000 claims description 9
- 244000052616 bacterial pathogen Species 0.000 claims description 7
- 230000002265 prevention Effects 0.000 claims description 7
- 241000588724 Escherichia coli Species 0.000 claims description 6
- 238000010411 cooking Methods 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 241000607142 Salmonella Species 0.000 claims description 4
- 230000008569 process Effects 0.000 abstract description 12
- 241000282472 Canis lupus familiaris Species 0.000 description 58
- 238000000855 fermentation Methods 0.000 description 31
- 230000004151 fermentation Effects 0.000 description 31
- 241000282326 Felis catus Species 0.000 description 27
- 239000000047 product Substances 0.000 description 27
- 235000005911 diet Nutrition 0.000 description 26
- 230000037213 diet Effects 0.000 description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 25
- 229910001868 water Inorganic materials 0.000 description 25
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 23
- 239000000203 mixture Substances 0.000 description 22
- 239000007789 gas Substances 0.000 description 16
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 15
- 241000589875 Campylobacter jejuni Species 0.000 description 15
- 239000000523 sample Substances 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 14
- 229920002472 Starch Polymers 0.000 description 14
- 238000001574 biopsy Methods 0.000 description 14
- 235000019698 starch Nutrition 0.000 description 14
- 239000008107 starch Substances 0.000 description 14
- -1 inulin Chemical compound 0.000 description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- 210000001072 colon Anatomy 0.000 description 12
- 238000005259 measurement Methods 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 238000000338 in vitro Methods 0.000 description 11
- 235000018102 proteins Nutrition 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 11
- 239000000758 substrate Substances 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 10
- 230000009286 beneficial effect Effects 0.000 description 10
- 230000000112 colonic effect Effects 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 9
- 235000019197 fats Nutrition 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 238000011534 incubation Methods 0.000 description 8
- 229920001223 polyethylene glycol Polymers 0.000 description 8
- 230000008901 benefit Effects 0.000 description 7
- 239000000470 constituent Substances 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- 150000004666 short chain fatty acids Chemical class 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 150000007513 acids Chemical class 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 6
- 235000014633 carbohydrates Nutrition 0.000 description 6
- 238000001030 gas--liquid chromatography Methods 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 238000012423 maintenance Methods 0.000 description 6
- SJWFXCIHNDVPSH-UHFFFAOYSA-N octan-2-ol Chemical compound CCCCCCC(C)O SJWFXCIHNDVPSH-UHFFFAOYSA-N 0.000 description 6
- 235000021391 short chain fatty acids Nutrition 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 229960000583 acetic acid Drugs 0.000 description 5
- 238000007792 addition Methods 0.000 description 5
- 108090000637 alpha-Amylases Proteins 0.000 description 5
- 238000009835 boiling Methods 0.000 description 5
- 235000010633 broth Nutrition 0.000 description 5
- 150000002066 eicosanoids Chemical class 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000002496 gastric effect Effects 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 239000002054 inoculum Substances 0.000 description 5
- 244000005706 microflora Species 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 230000004083 survival effect Effects 0.000 description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- 235000011114 ammonium hydroxide Nutrition 0.000 description 4
- 239000000679 carrageenan Substances 0.000 description 4
- 229920001525 carrageenan Polymers 0.000 description 4
- 235000010418 carrageenan Nutrition 0.000 description 4
- 229940113118 carrageenan Drugs 0.000 description 4
- 239000007795 chemical reaction product Substances 0.000 description 4
- 230000013872 defecation Effects 0.000 description 4
- 230000007661 gastrointestinal function Effects 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 239000000413 hydrolysate Substances 0.000 description 4
- 230000002757 inflammatory effect Effects 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 230000000670 limiting effect Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 235000013372 meat Nutrition 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 229910000033 sodium borohydride Inorganic materials 0.000 description 4
- 239000012279 sodium borohydride Substances 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 150000008163 sugars Chemical class 0.000 description 4
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 4
- 238000012935 Averaging Methods 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical group CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 241001281643 Solus Species 0.000 description 3
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 3
- 235000011054 acetic acid Nutrition 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 238000000540 analysis of variance Methods 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 235000019864 coconut oil Nutrition 0.000 description 3
- 239000003240 coconut oil Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid group Chemical class C(CCCCCC)(=O)O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 235000009973 maize Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 150000004667 medium chain fatty acids Chemical class 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 235000003170 nutritional factors Nutrition 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000001117 sulphuric acid Substances 0.000 description 3
- 235000011149 sulphuric acid Nutrition 0.000 description 3
- MCTWTZJPVLRJOU-UHFFFAOYSA-N 1-methyl-1H-imidazole Chemical compound CN1C=CN=C1 MCTWTZJPVLRJOU-UHFFFAOYSA-N 0.000 description 2
- 206010051226 Campylobacter infection Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 108010068370 Glutens Proteins 0.000 description 2
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 2
- 229920000294 Resistant starch Polymers 0.000 description 2
- 238000005903 acid hydrolysis reaction Methods 0.000 description 2
- 102000004139 alpha-Amylases Human genes 0.000 description 2
- 229940024171 alpha-amylase Drugs 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000006556 fastidious anaerobe broth Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000012737 fresh medium Substances 0.000 description 2
- 239000013505 freshwater Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 235000021312 gluten Nutrition 0.000 description 2
- 235000013882 gravy Nutrition 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 239000008274 jelly Substances 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000003801 milling Methods 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000021254 resistant starch Nutrition 0.000 description 2
- 230000001523 saccharolytic effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 235000011888 snacks Nutrition 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000001228 trophic effect Effects 0.000 description 2
- HNLXNOZHXNSSPN-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(OCCOCCOCCOCCOCCOCCOCCO)C=C1 HNLXNOZHXNSSPN-UHFFFAOYSA-N 0.000 description 1
- TUAMRELNJMMDMT-UHFFFAOYSA-N 3,5-xylenol Chemical compound CC1=CC(C)=CC(O)=C1 TUAMRELNJMMDMT-UHFFFAOYSA-N 0.000 description 1
- XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 108010077805 Bacterial Proteins Proteins 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 240000008886 Ceratonia siliqua Species 0.000 description 1
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 1
- 244000298479 Cichorium intybus Species 0.000 description 1
- 235000007542 Cichorium intybus Nutrition 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- 206010012741 Diarrhoea haemorrhagic Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 244000287680 Garcinia dulcis Species 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 235000019687 Lamb Nutrition 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-N Metaphosphoric acid Chemical compound OP(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-N 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 102000001746 Pancreatic alpha-Amylases Human genes 0.000 description 1
- 108010029785 Pancreatic alpha-Amylases Proteins 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical class [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 240000000359 Triticum dicoccon Species 0.000 description 1
- 241001541238 Vachellia tortilis subsp. raddiana Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- LGDAGYXJBDILKZ-UHFFFAOYSA-N [2-methyl-1,1-dioxo-3-(pyridin-2-ylcarbamoyl)-1$l^{6},2-benzothiazin-4-yl] 2,2-dimethylpropanoate Chemical class CC(C)(C)C(=O)OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 LGDAGYXJBDILKZ-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- PNXNSVYZNGNYIN-UHFFFAOYSA-N acetic acid;butanoic acid;propanoic acid Chemical compound CC(O)=O.CCC(O)=O.CCCC(O)=O PNXNSVYZNGNYIN-UHFFFAOYSA-N 0.000 description 1
- 150000001243 acetic acids Chemical class 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 235000004251 balanced diet Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 150000001559 benzoic acids Chemical class 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- PASOAYSIZAJOCT-UHFFFAOYSA-N butanoic acid Chemical compound CCCC(O)=O.CCCC(O)=O PASOAYSIZAJOCT-UHFFFAOYSA-N 0.000 description 1
- 229920005549 butyl rubber Polymers 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 235000012182 cereal bars Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000000369 enteropathogenic effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 244000000036 gastrointestinal pathogen Species 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 239000005337 ground glass Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000010874 in vitro model Methods 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 235000021073 macronutrients Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 238000001139 pH measurement Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 230000003334 potential effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000004672 propanoic acids Chemical class 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000009561 snack bars Nutrition 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- CNGSOCHSRNOEDQ-UHFFFAOYSA-M sodium;boric acid;chloride Chemical compound [Na+].[Cl-].OB(O)O CNGSOCHSRNOEDQ-UHFFFAOYSA-M 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 235000000891 standard diet Nutrition 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000013595 supernatant sample Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 235000021195 test diet Nutrition 0.000 description 1
- 239000003104 tissue culture media Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
- 235000019801 trisodium phosphate Nutrition 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S426/00—Food or edible material: processes, compositions, and products
- Y10S426/805—Pet food for dog, cat, bird, or fish
Definitions
- the present invention relates to the use of coconut endosperm fibre as a dietary fibre component in a pet food product, to the use of coconut endosperm fibre in the manufacture of a pet food product, to a pet food product which comprises coconut endosperm fibre, to a process for making such a pet food product and to a method comprising feeding such a pet food product to a pet animal.
- the present invention also relates to the use of coconut endosperm fibre in reducing and preventing intestinal inflammation and in reducing and preventing pathogenic bacterial infection in the large intestine of a pet animal.
- Pet health can be monitored in a number of ways. Two of these are faeces quality and gastrointestinal (GI) tract health. Good quality faeces in pet animals is of two-fold importance. Firstly, it is a good indicator of a healthy pet. It is known that good faeces quality usually reflects healthy colonic structure and function. Secondly, it is a much favoured practicality for pet-owners. Accordingly, the maintenance of good quality pet faeces and the ability to improve the quality of pet faeces is a constantly ongoing aim in the art. It is also an ongoing aim in the art to improve the GI tract health of pet animals. The ability to maintain and improve GI tract health can be beneficial to pet owners because it has an impact on their pet's overall health.
- GI gastrointestinal
- One method for maintaining normal gastrointestinal function and ameliorating chronic diarrhoea in animals has included the addition, in pet food products, of a fibre source.
- Fibre has wide ranging effects on bowel habit, increasing faecal output, reducing transit times and altering colonic metabolism. Many of the beneficial effects of fibre relate to its extensive break-down in the large intestine. This anaerobic process, termed fermentation, is the principle metabolic event occurring in the colon. Fermentation is a digestive function of the complex assemblage of microorganisms that inhabit the large intestine, which break-down complex carbohydrates and other substrates that have not been hydrolysed and absorbed in the upper intestine. Both the microbiotia and the host benefit from this association.
- SCFAs short chain fatty acids
- gases and energy The major complex carbohydrate fermentation products are short chain fatty acids (SCFAs), gases and energy.
- the energy generated is used for microbial cell growth which routes much of the colonic nitrogen into bacterial protein and increased microbial mass.
- SCFAs are rapidly absorbed and can influence gastrointestinal function by providing energy substrates to the colonic mucosa and by promoting water and electrolyte adsorption from the colonic lumen. Gas produced during fermentation is eliminated both through the lungs and as flatus.
- bacteria will resort to the breakdown of protein which provides much less energy in the form of branched chain fatty acids and also metabolites that are potentially toxic to the host (ammonia, amines, phenols etc.).
- a useful dietary fibre In the production (or manufacture) of commercial pet food products, a small number of different technologies are used. In all cases, product components are mixed together (often, but not necessarily with cooking/heating) with optional other components added later on, and then transported to the various containers to be filled.
- the process may include extrusion cooking, for example in the production of a dry product. Alternatively, the process may include emulsion milling in the production of "chunks" .
- a variety of processes will include the pumping of the product from one part of the processing apparatus to another and optionally further into cans. It is always desirable to obtain a combination of ingredients which maximise the processing of the ingredients through to the final product. It is a further object of the present invention to provide a dietary fibre which is particularly suitable in the manufacturing process.
- the present invention relates to providing, in a pet food product, a useful fibre source.
- the fibre source is particularly easy to use in the manufacture of a pet food product.
- a first aspect of the invention provides the use of coconut endosperm fibre as a dietary fibre component in a pet food product.
- the first aspect of the invention includes the use of coconut endosperm fibre as a dietary fibre component in the manufacture of a pet food product.
- the coconut endosperm fibre may be used as the single dietary fibre component or in combination with one or more other dietary fibre components, such as beet pulp, chicory, citrus pulp, rice bran, carob bean or gum talha.
- Fresh coconut endosperm has a typical nutrient distribution of water (35%), oil (44%), protein (6%), sugars (7%), fibre (3 %) and ash (1 %).
- the coconut endosperm fibre may be fresh or in any other form such as copra defatted copra (also referred to, amongst others, as copra cake, copra presscake or copra meal) coconut flour, defatted coconut flour, full or defatted desiccated coconut, copra, or degraded coconut endosperm which has been heated or enzymatically treated.
- Copra is a particularly suitable source of coconut endosperm fibre for use according to the present invention.
- Copra is dried coconut endosperm (usually sundried).
- Defatted copra is also particularly suitable.
- Defatted copra is the typical result of coconut endosperm which has been dried and had the coconut oil mechanically removed.
- Defatted copra cake is obtained by first obtaining copra, then crushing the copra through a press or expeller to remove most of the oil. The residue remaining is termed copra cake, copra presscake, or copra meal.
- the addition of coconut endosperm fibre into a pet food product is believed to i) maintain good faeces quality or improve the faeces quality of a pet and/or ii) maintain good GI tract health or improve it, either achieved by one or more of the following: the improvement of faeces water binding, the reduction of faecal pH, the increased production of beneficial end products and decreased production of detrimental end products of microbial fermention, the enhancement of populations of beneficial bacteria, the enhancement of water/electrolyte uptake in the gastrointestinal tract, the improvement of colonic structure/health and the provision of good water binding features to equalise faecal texture.
- the present invention is useful for healthy animals, including sensitive animals as well as animals that suffer from poor faeces quality or poor GI tract health. Accordingly, the first aspect of the invention also relates to the use of coconut endosperm fibre in the manufacture of a pet food product for use in maintaining or improving the faeces quality of a pet animal, or for use in maintaining or improving GI tract health. Poor faeces quality is described in Appendix 1
- Evaluation of faeces quality and the identification of maintenance or improvement of faeces quality are techniques well known and used in the art. More than one method can be used (alone or in combination). Methods commonly use a panel of trained observers (may be trained members of the public or professionals). Faecal samples from a pet are collected and may be scored according to a rating system outlined in Appendix 1. The evaluation of good faecal quality is determined according to faecal quality which often reflects a normal gastrointestinal function. This is usually the formation of a stool which is firm and retains its shape.
- Stools which are hard, pellet-like and dry (and may be produced with straining), or which are produced with a moisture content such that shape is not retained (including diarrhoea), do not represent normal gastrointestinal function.
- the precise optimum stool consistency may vary somewhat between different types of pet animals and between species of an animal, but can be easily determined on review by a person skilled in the art.
- Evaluation of good GI tract health and the identification of improvement of GI tract health are also techniques well known and used in the art.
- the evaluation of maintained or improved GI health can be determined by comparison of a pet animal fed on the same diet but without the coconut endosperm fibre.
- Colonic (or intestinal or digestive) health can be defined in terms of stool quality and pH, the presence and numbers of beneficial and potentially harmful bacteria in the lumen of the GI tract and/or faeces and total and specific short chain fatty acids.
- the present invention has been shown to be particularly useful in the ability to increase the production of butyrate from the fermentation of coconut endosperm fibre and thus increase the availability of butyrate in the gut.
- Butyrate is one SCFA of particular interest due to the trophic effects it can exert on colonocytes, as well as its beneficial metabolic role.
- increased levels of butyrate production were observed alongside increased values seen with substrates known to produce high levels of butyrate, such as inulin, in the same test system.
- coconut endosperm fibre is also a useful component of the invention due to its role in preventing or treating pathogenic bacterial infection in an animal's large intestine. Pathogenic infection in the large intestine may be clinical or sub-clinical. Both types of infection are deleterious to the health of the animal and to the animal's faeces quality. More details on the role of coconut endosperm fibre are described below in relation to the sixth and seventh aspects of the invention. The details as given for the sixth and seventh aspects of the invention also apply to the first to fifth aspects of the invention.
- coconut endosperm fibre in a pet food product reduces the inflammatory status of an animal's colon or maintains a low inflammatory status of an animal's colon. More details on the role of coconut endosperm fibre in reducing the inflammatory status of an animal's colon are described below in relation to the eighth and ninth aspects of the invention.
- the remaining components of the pet food product are not essential to the invention and typical standard products can be combined with the required coconut endosperm fibre content.
- the combined ingredients of the pet food product according to the invention provide all of the recommended vitamins and minerals for the particular pet in question, (a complete and balanced food), for example, as described in National Research Council, 1985, Nutritional Requirements for Dogs, National Academy Press, Washington D.C. (ISBN: 0-309-03496-5); National Research Council, 1986, Nutritional Requirements of Cats, National Academy Press, Washington D.C. (ISBN: 0-309-03682-8) or Association of American Feed Control Officials, Official Publication 1996.
- the coconut endosperm fibre sources of the present invention are, for a further reason, also particularly useful and effective as a component of a pet food product. This is because the fibre source, in most cases, will contain useful levels of other nutritional factors, such as fat and protein. The presence of such other nutritional factors is due to their presence (and the proportions of their presence) in the originating source of the fibres (the coconut endosperm). It is known that coconut oil is high in medium chain fatty acids (MCFAs) and that such MCFAs are more readily absorbed in the gut of animals.
- MCFAs medium chain fatty acids
- the coconut oil present in the source of the coconut endosperm fibres (even in defatted copra cake, which contains in the region of 5-10% fat on a dry matter basis) provides a key nutritional factor for the animal. Since such oil is a particularly good source of readily absorbed fatty acids, the presence of the oil in the fibre source is especially useful in certain groups of compromised pet animals.
- the level of coconut endosperm fibre incorporated into a pet food product as a dietary fibre component is not limiting.
- the fibre component of coconut endosperm is present in the pet food product at a level of from approximately 0J5 to 8% on a dry matter basis, preferably 0J5 to 5% on a dry matter basis as measured by the Englyst method (as defined in Englyst H.N. , and Cumming J.H. (1984), Simplified method for the measurement of total non-starch polysaccharides by gas- liquid chromatography of constituent sugars as alditol acetates. Analyst. 109, 937- 942, and incorporated herein by reference).
- the levels may go from 0.15% up to 5%, 6% , 7% or 8% .
- the lower limit may be from 1.5% , 2% or 3% .
- a description of the Englyst method is described in Appendix 2. In principle, starch is removed enzymatically after solubilisation and
- NSP is measured as the sum of the constituent sugars released by acid hydrolysis.
- the starch component of the fibre source is gelatinised by boiling in hot water and is then removed with alpha-amylase and pullulanase.
- Starch and modified, or resistant starch are dispersed in DMSO.
- Three samples are then subjected to complementary procedures measuring (i) total NSP (ii) water-soluble NSP and (iii) cellulose. Components are hydrolysed in each case with sulphuric acid.
- the constituent sugars are converted to alditols and are measured as their alditol acetates using gas-liquid chromatography (GLC). Values for total dietary fibre as well as insoluble and soluble fractions can be obtained.
- Cellulose can be measured separately and the non-cellulosic polysaccharides are characterised by measurement of the individual monosaccharides .
- the incorporation of the level of coconut endosperm fibre can easily be determined by identifying the amount of dietary fibre in the particular form of the coconut endosperm fibre.
- defatted copra contains approximately 33.5% total dietary fibre.
- the preferred amount of defatted copra in a pet food product in order to provide a preferred fibre level of from approximately 0J5 to 5% on a dry matter basis according to the first aspect of the invention is at a level from approximately 0.5 to 15% on a dry matter basis of the pet food product.
- the invention is particularly applicable to mammalian pet animals, especially dogs, cats and horses.
- the pet food product according to the present invention is preferably a commercial pet food product.
- a product is preferably sold as a product for feeding to a pet animal, in particular a pet cat or a pet dog.
- the pet food product is preferably packaged. In this way, the consumer is able to identify, from the packaging, the ingredients in the food product and confirm that it is suitable for the particular pet in question.
- the packaging may be metal (usually in the form of a tin or flexifoil), plastic, paper or card.
- the pet food may be a dry, semi-moist or a moist product.
- Wet food includes food which is sold in tins and has a moisture content of 70 to 90% .
- Dry food includes food having a similar composition, but with 5 to 15 % moisture and presented as small biscuit-like kibbles. The amount of moisture in any product may influence the type of packaging which can be used or is required.
- the pet food product according to the present invention encompasses any product which a pet consumes in its diet.
- the invention covers standard food products as well as pet food snacks (for example, snack bars, cereal bars, snacks, biscuits and sweet products).
- the food product is preferably a cooked product. It may be in the form of a gelatinized starch matrix. It may be in the form of chunks in gravy, jelly, loaf or water. It may incorporate meat or animal derived material (such as beef, chicken, turkey, lamb, pork, fish, blood plasma, marrow bone etc or one or more thereof).
- the product alternatively may be meat free (preferably including a meat substitute such as soya, maize gluten or a soya product) in order to provide a protein source.
- the product may contain additional protein sources such as soya protein concentrate, milk proteins, gluten etc.
- the product may also contain a starch source such as one or more grains (e.g. wheat, corn, rice, oats, barley etc), or may be starch free.
- a typical dry dog or cat food contains about 20-30% crude protein, about 10-20% fat, the remainder being carbohydrate, including dietary fibre and ash.
- a typical wet or moist product contains (on a dry matter basis) about 40% fat, 50% protein and the remainder being fibre and ash.
- the present invention is particularly relevant for a pet food product as herein described which is sold as a pet food, in particular, a pet food for a dog or a cat.
- Cats and dogs according to the present invention are preferably Felis domesticus or Canis domesticus.
- a second aspect of the invention provides the use of coconut endosperm fibre in the manufacture of a pet food product.
- the second aspect of the present invention does not include such a use to manufacture a pet food product which includes a gel comprising coconut endosperm and carrageenan.
- a pet food product which includes a gel comprising coconut endosperm and carrageenan has previously been described in WO96/39046.
- the disclosure in WO96/39046 is limited to a gelling system comprising carrageenan and coconut endosperm.
- the use of the endosperm in WO96/39046 is only as a component of a gelling system.
- coconut endosperm fibre in the manufacture of a pet food product (in accordance with the second aspect of the invention) has the advantages described above according to the first aspect of the invention.
- coconut endosperm fibre sources are particularly suitable dietary fibres for a pet food manufacturing process.
- the use of coconut endosperm as a dietary fibre is extremely satisfactory.
- the coconut endosperm fibre advantageously and surprisingly generates less emulsion viscosity when added to the remainder of the product ingredients compared to the use of other fibre sources.
- the advantages of such a fibre are especially noted in the process of pumping and forming the product. It is particularly useful in the process of "emulsion milling" in the production of "chunks" .
- the use of a coconut endosperm fibre source does not lead to a grey colour, following processing, often associated with some other fibre sources. Instead, an aesthetically acceptable colour is obtained.
- a third aspect of the invention provides a pet food product which comprises coconut endosperm fibre.
- the third aspect of the present invention does not include a pet food product which includes a gel comprising coconut endosperm and carrageenan as in WO96/39046.
- the pet food product according to the third aspect of the invention has the advantages as described above for the first and second aspects of the invention. These include; the promotion of good faeces quality and GI health, in particular the levels of the SCFA butyrate following fermentation, and surprisingly good processing qualities.
- the pet food product is particularly suitable for feeding to a pet animal.
- All preferred features of the first and second aspect also apply to the third. These include levels and sources of coconut endosperm fibre, types of food products, manufacturing and other components of the food product.
- a fourth aspect of the present invention provides a process for preparing a pet food according to the third aspect of the invention comprising mixing the ingredients with optional heating/cooking.
- the pet food product may be formed before or after the mixing and/or the heating/cooking.
- coconut endosperm fibres provides a number of advantages over the incorporation of other fibres in the process for preparing a pet food product and in the resulting pet food product.
- the process comprises mixing a source of coconut endosperm fibre with one or more ingredients of a pet food product.
- the product can in all other ways be produced by processes known in the art.
- the coconut endosperm fibre may be added prior to or following heating or cooking of one or more of the other ingredients.
- the process may also include the step of extracting the coconut endosperm fibre from coconut material.
- the food product can be made according to any method known in the art, such as in Waltham Book of Dog and Cat Nutrition, Ed. ATB Edney, Chapter by A. Rainbird, entitled “A Balanced Diet” in pages 57 to 74 Pergamon Press Oxford.
- a fifth aspect of the invention provides a method comprising feeding a pet animal a pet food product according to the third aspect of the invention.
- the fifth aspect of the invention includes a method for maintaining or improving gastrointestinal tract health in a pet animal, the method comprising feeding the animal a pet food product according to the third aspect of the invention.
- Feeding the pet animal with the pet food product according to the third aspect of the invention maintains or improves the GI health of the animal by the presence of the coconut endosperm fibre.
- the animal is fed the pet food product in a sufficient quantity and for a sufficient time period in order to maintain or improve the GI health.
- a particular GI health improvement is due to the SCFA production, in particular butyrate production.
- the fifth aspect of the invention includes a method for maintaining or improving faeces quality in a pet animal, the method comprising feeding the animal a pet food product according to the third aspect of the invention.
- Feeding the pet animal with the pet food product according to the third apsect of the invention maintains or improves faeces quality by the presence of the coconut endosperm fibres.
- the animal is fed the pet food product in a sufficient quantity and for a sufficient time period in order to maintain or improve faeces quality.
- the quantity and time period for feeding according to the fifth aspect of the invention will depend on a number of factors including type of animal, breed, age and general state of health, which the pet feeder can easily use to determine quantity of food and time period for feeding.
- the method of the fifth aspect may be, but is not restricted to, veterinarian treatment.
- the feeding may be non-therapeutic.
- feeding also including the meaning of "administration” to an animal.
- the methods may be prophylactic or therapeutic.
- the preferred features of the first to fourth aspects of the invention also apply to the fifth aspect. These include levels and sources of coconut endosperm fibre, types of food products, manufacturing and other components of the food product.
- a sixth aspect of the invention provides for the use of coconut endosperm fibre in the manufacture of a pet food product for the prevention or treatment of pathogenic bacterial infection in the large intestine of a pet animal.
- pathogenic bacteria include Campylobacter (especially Campylobacter jejuni), Salmonella and Escherichia coli. Campylobacter jejuni, the species responsible for the majority of human infections, is also the main species of concern for cats and dogs. The species can act as a pathogen in young dogs and cats and is likely to be opportunistic in older animals. Clinical illness in dogs manifests itself as diarrhoea, ranging from mild to mucus laden bloody diarrhoea, tenesmus, vomiting, anorexia and depression.
- Campylobacter infection in companion animals is the zoonotic risk that carriage and excretion of the organism represents. It has been estimated that 5% of all human C. jejuni induced diarrhoea results from exposure to infected dogs or cats. A number of more recent studies quote dog ownership as a significant risk factor for becoming ill with Campylobacter. A study conducted in Wales, New Zealand found that household contact with dogs carried a risk of 1.25 to 2 times for contracting Campylobacter. In addition, there are concerns that attempts to reduce and eliminate Campylobacter infection by continued use of antibiotic strains may lead to the emergence of antibiotic resistant strains of this organism.
- the present invention of a pet food product comprising coconut endosperm fibre has been shown to be effective in preventing and treating pathogenic bacterial infection in the large intestine of a pet animal.
- the animal is, in particular, a cat or a dog (in both cases, preferably Felis domesticus or Canis domesticus).
- Pathogenic bacteria include, amongst others, Campylobacter, Salmonella, pathogenic Clostridium and E. coli, such as enteropathogenic E. coli and verotoxigenic E. coli.
- a seventh aspect of the invention provides a method for preventing or treating pathogenic bacterial infection in the large intestine of a pet animal, the method comprising feeding said pet animal a pet food product comprising coconut endosperm fibre.
- An eighth aspect of the invention provides for the use of coconut endospern fibre in the manufacture of a pet food product for the prevention or treatment of intestinal inflammation in a pet animal.
- the present invention shows that pet animals which are fed a pet food product comprising coconut endosperm fibre produce significantly less PGE 2 than the same diet without a fibre source.
- a ninth aspect of the invention provides a method for preventing or reducing intestinal inflammation in a pet animal, the method comprising feeding said pet animal a pet food product containing coconut endosperm fibre.
- the animal is a canine animal.
- the coconut endosperm fibre may be in any form and preferably as described for the first to fifth aspects of the invention.
- the coconut endosperm fibre is preferably present at a level of from 0J5 to 5% , on a dry matter basis, in the pet food product, as measured by the Englyst method. All other preferred features are as for the first to fifth aspects of the invention.
- Figure 1 shows a comparison of faeces scores between two diets containing copra presscake
- Figure 2 shows a graph of the effect of the inclusion of coconut endosperm fibre in the canine large intestine model on the survival of Campylobacter jejuni;
- Figure 3 shows mean eicosanoid prostaglandin E 2 production by colonic biopsy samples.
- This example describes the preparation and use of defatted dried coconut flour.
- coconuts were obtained from the local market and the white flesh or endosperm recovered. The endosperm was finely ground and repeatedly extracted with acetone to remove the fat and water. A dried defatted coconut powder was obtained.
- This example describes the preparation of mechanically defatted copra cake.
- Coconut endosperm, stripped from a coconut was crushed.
- the crushed material was heated to a maximum 120 °C using techniques widely known in the art of oilseed processing, and passed through a hydraulic press or expeller to remove most of the oil.
- the extract obtained by this process was dried, if necessary to obtain a product with a moisture content of approximately 15% .
- the raw material evaluated in this in vitro fermentation system is particularly suitable for addition to dry and canned dog and cat products
- the raw material was analysed for total dietary fibre using Englyst and AOAC methodologies (Table 2.)
- the AOAC methodology can be found in -AOAC International 1995, Total, Soluble and Insoluble Dietary Fibre in Foods.
- the Englyst methodology is referred to previously in this text and in Appendix 2.
- Dietary fibre analysis revealed significant differences in total dietary fibre levels between the raw materials. Analysis by AOAC generally produced a higher percentage of total dietary fibre compared with analysis by Englyst.
- the Englyst technique uses enzymic-chemical methods to measure non-starch polysaccharides (NSP), the major structural components of plant cell walls, which encapsulates the more traditional definition of dietary fibre.
- NSP non-starch polysaccharides
- the AOAC technique measures fibre using a combination of enzymatic and gravimetric methods that incorporate lignin and some resistant starch leading to the higher total dietary fibre levels.
- Fibre Sample Preparation (Day 1) • Fibre substrates were provided as copra cake at a concentration of 0.7% (w/v). 0.231g ( ⁇ 0.05g) of copra cake was weighed into triplicate 60 ml glass serum bottles (Jencons) and the exact weight recorded. 30 mis of fermentation media (Table 4) was added and bottles were capped with a cotton wool bung and were covered with metal foil.
- Cat or dog faeces were used as a source of bacterial inoculum for the in vitro fermentation system. Cats were fed the following dry complete diet for at least 3 months prior to the start of the study. Dogs were fed the following dry diet formulated for adult maintenance for at least 2 months prior to the start of the study.
- Cats were housed in lodges to enable collection of fresh faeces for a J week period with a subsequent one week break. Cats were fed diets solus in amounts required to maintain body weight and had access to fresh water at all times.
- a fresh faecal sample was collected. 20g of wet faeces were added to the pre- reduced phosphate buffer within 60 min of defecation. The flask was placed on a magnetic stirrer in the anaerobic cabinet to generate a faecal resuspension slurry
- Time point measurements were taken at 0, 6 and 24 hr post-faecal incoulum.
- Control samples that contained no external substrate produced significant levels of SCFA and gas.
- the basal production from the control samples has been subtracted from that in substrate-added samples to yield the production caused by the coconut endosperm fibre source.
- Positive values represent additional production above the basal level, and negative values show an inhibited production, or a consumption compared with controls.
- Negative values for pH represent a decrease of the pH (results shown in Tables 6 and 7).
- the total SCFA produced were investigated in more detail by characterising the constituent SCFA.
- In vivo acetic, propionic and butyric acids are the principle end- point of carbohydrate fermentation and account for 90% of the total SCFA in the colon.
- Butyrate Butyrate is of particular interest due to the trophic effects it can exert on colonocytes, as well as its beneficial metabolic role.
- the production of butyrate was significantly enhanced (p ⁇ 0.05) above control production in the presence of defatted copra presscake after 6 and 24 hr with cat (Table 6).
- the cat after 24 hr an 80% increase in the production of butyrate from defatted copra presscake was observed. This near doubling of butyrate levels may have biological significance in vivo. An increase was observed with dog after 24 hr, but this was not significant (Table 7).
- Gas is a second major end product of fermentation.
- the major components of gas are CO 2 , H 2 and CH 4 which result principally from carbohydrate fermentation. Gas production has been measured as an increase in pressure (mBar) over time.
- #Total SCFA is total production of acetic, propionic, N-butyric, Iso-butyric, valeric,
- #Total SCFA is total production of acetic, propionic, N-butyric, Iso-butyric, valeric, Iso-valeric, caprioc, Iso-caproic, heptanoic acids.
- the objective of the trial was to assess the faeces quality performance of twojecipes containing defatted copra presscake.
- the base pet foods used were canned chunks in jelly product.
- the recipe ingredients for each diet was:
- Recipe 1 total is higher than 100% due to oven loss (oven yield 90%). All cans were processed at 125°C for 61 minutes.
- the faeces quality was measured in a two-week cross-over trial, on a panel of 10 adult dogs representing a number of different breeds.
- the dogs used for the trial were:
- Miniature Schnauzer 10 The dogs were offered the following amounts of diet each day (g/day based on maintenance feeding levels):
- Faeces quality was measured subjectively using the 17 category faeces scoring scale, whereby all defecations were graded (in quarter grades) between 1 and 5 (see Appendix 1).
- the mean faeces score was calculated for each dog using all faeces scores collected during the trial period.
- An overall mean faeces score for the diet was calculated by averaging the means for each dog.
- Statistical analysis was conducted using 2-way ANOVA (with diet as a fixed factor and dog as a variable factor).
- Figure 1 shows a comparison of mean faeces score and 95% LSD (Least Square Difference) intervals for the diets.
- the objective of the trial was to assess the faeces quality performances of a dry recipe containing copra presscake.
- the base pet food used was an extruded mono component dry product.
- the recipe ingredients are as follows:
- the faeces quality was measured in a one week trial, on a panel of 14 adult dogs representing a number of different breeds.
- the dogs used for trial were:
- the dogs were fed to maintenance energy requirements.
- Faeces quality was measured subjectively using the 9 category faeces scoring scale, whereby all defections were graded (in half grades) between 1 and 5 (see Appendix 1).
- the mean faeces score was calculated for each dog using all faeces scores collected during the trial period.
- An overall mean faeces score for the diet was calculated by averaging the means for each dog.
- Campylobacter is one of the most predominant gastrointestinal pathogens causing both clinical and non-clinical infections in dogs.
- C. jejuni cells were grown from stock cultures and cultured at 37°C under microaerobic conditions (5% O 2 , 10% CO 2 and 85% N 2 ). Liquid cultures were grown in 20ml volumes in 50ml conical flasks shaken on an orbital shaker. Overnight cultures grown in Mueller Hinton (MH) broth (Oxoid) were adjusted to A ⁇ 1.0 before incusion in the assay.
- MH Mueller Hinton
- Flasks were set up with 200ml MH broth, 1ml of the adjusted C. jejuni culture, and 2g fresh faeces. To test flasks, 0.7% (w/v) copra cake was added and swirled to mix. Control flasks had no further additions.
- Flasks were sampled at the start (0 hours) and end (24 hours) of the experiment to determine viable counts of C. jejuni cells by serially diluting samples from the flasks and plating dilutions on to Campylobacter selective agar (LabM). Plates were incubated microaerobically for 48 hours, after which viable numbers were determined.
- Figure 2 shows a graph of the effect of the inclusion of coconut endosperm fibre in the canine large intestine model on the survival of Campylobacter jejuni. Letters denote statistically significant difference.
- the trial involved 7 dogs representing a number of breeds. Dogs were housed individually for the duration of the feeding and measurement periods. The trial was carried out as a cross-over. Dogs were fed the diet solus in amounts required to maintain body weight (125 x BW 075 ) with access to drinking water at all times for 4 weeks with a one week washout.
- the test diet was a nutritionally complete wet format that consisted of oven formed meat chunks that were canned in water. Coconut endosperm fibre was included at 7.2% (w/w). All other recipe components were reduced pro rata for the inclusion of coconut endosperm fibre in the form of copra cake.
- the washout diet was a complete and balanced diet.
- Biopsies were taken from mid-colon, transported in tissue culture media (RPMI plus gentomycin) and weighed.
- the biopsy samples were washed in fresh media for 30 minutes and transferred to a fresh 24-well multiwell plate containing lml of media and cultured for 24 hours at 37°C with 5% CO 2 .
- the biopsy samples were then spun down at 13000rpm for 5 minutes and the supernatant transferred to a fresh eppendorf tube and frozen at -20°C until required.
- 0.5ml of 1 % triton lysis buffer (20mM Tris Ph7.5, 20mM NaCl 2 , 1 % triton x 100) was added to the biopsy sample and left for a minimum of 1 hour.
- the samples were then homogenised briefly and total protein content measured using Sigma Microprotein-PRTM kit. Total biopsy protein was found to significantly correlate with biopsy wet weight and used to standardise eicosanoid production to biopsy sample size.
- PGE 2 production by mid-colonic biopsy samples were measured by enzyme immunoassay (EIA).
- EIA tests were obtained from R&D Systems and performed as described in provided protocol sheets.
- lOOul sample and PGE 2 standard was added to 96 well microplate previously coated with goat anti-mouse/rabbit polyclonal antibody.
- 50 ⁇ l PGE 2 conjugated to alkaline phosphatase and 50 ⁇ l mouse polyclonal antibody to PGE 2 were added. The plate was incubated for 2 hours at room temperature on a horizontal orbital plate shaker set at 500 ⁇ 50rpm. After incubation the plate was washed and 200 ⁇ l pNPP substrate added.
- the 17 point scoring scale is used to assess all defecations, whereby faeces are scored in quarter grade increments between grade 1 and grade 5.
- the 9 point scoring scale is used to assess all defecations, whereby faeces are scored in half grade increments between grade 1 and grade 5.
- the half grade demarcations are:
- Grade 5 Watery diarrhoea Grade 4.5 - Diarrhoea with some areas of consistency Grade 4 - The majority, if not all of the form is lost, poor consistency, viscous Grade 3.5 - Very moist, but still has some definite form
- Grade 3 - Moist beginning to lose form, leaving a definite mark when picked up Grade 2.5 - Well formed, slightly moist surface, leaves a mark, sticky to touch
- the mean faeces score produced by each dog is calculated and then an overall mean is determined for the whole trial by averaging the mean faeces scores from each dog.
- the fractionation procedure was carried out in 50-60ml screw-topped glass centrifuge tubes as previously described.
- Gas-liquid chromatography was performed with a Pye Unicam Series 204 chromatograph, fitted with a flame-ionisation detector.
- a 2Jm x 2mm i.d. glass column packed with Supelcoport (100-200 mesh) coated with 3% SP 2330 was used.
- the column temperature was 215°C (isothermal) and the injector and detector temperatures were 250°C.
- the carrier gas (nitrogen) flow-rate was 20ml min- 1 .
- Enzyme preparations were as follows: hog pancreatic ⁇ -amylase, E.C.3.2. L (Sigma, Cat. No. A4268); pullulanase, E.C.3.2. L41. (Boehringer, Cat. No. 108944).
- foods with a low water content can be ball milled for 2-3 minutes, and those with a higher water content homogenised, or freeze-dried and ball milled.
- Samples with dry matter between 90 and 100% and with less than 203% of fat can be analysed directly. Otherwise, add 40ml of acetone, mix for 30 minutes by using a magnetic stirrer, centrifuge and remove by aspiration as much of the supernatant as possible without disturbing the residue. Place the tubes in a water bath at 65°C on a magnetic stirrer hot plate and mix the residue for a few minutes until it appears to be dry. The beaker can be covered and the acetone vapour removed by water pump.
- Acid hydrolysis of the residue from enzymic digestion Disperse the dried residue in 1ml of 12M sulphuric acid, using a vortex mixer.
- the method used is a modification of the method of Scott.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Physiology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
Claims
Priority Applications (17)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR0008879-0A BR0008879A (en) | 1999-03-10 | 2000-03-10 | Pet food product, process for preparing it, method for feeding an animal, use of coconut endosperm fiber, and methods for preventing or treating a pathogenic bacterial infection in a pet's large intestine and intestinal inflammation in an animal |
CA002366920A CA2366920C (en) | 1999-03-10 | 2000-03-10 | Pet food product with coconut endosperm fibre |
MXPA01009101A MXPA01009101A (en) | 1999-03-10 | 2000-03-10 | Pet food product with coconut endosperm fibre. |
JP2000603528A JP4970656B2 (en) | 1999-03-10 | 2000-03-10 | Pet food products containing coconut endosperm fiber |
DE60028735T DE60028735T2 (en) | 1999-03-10 | 2000-03-10 | PET FOOD WITH COCONUT OIL FIBER |
EP00909476A EP1158867B1 (en) | 1999-03-10 | 2000-03-10 | Pet food product with coconut endosperm fibre |
US09/936,036 US6656512B1 (en) | 1999-03-10 | 2000-03-10 | Pet food product with coconut endosperm fiber |
AU31758/00A AU776479B2 (en) | 1999-03-10 | 2000-03-10 | Pet food product with coconut endosperm fibre |
PL00350537A PL350537A1 (en) | 1999-03-10 | 2000-03-10 | Pet food product with coconut endosperm fibre |
GB0121705A GB2363696B (en) | 1999-03-10 | 2000-03-10 | Pet food product with coconut endosperm fibre |
DE60114778T DE60114778T3 (en) | 2000-03-10 | 2001-03-09 | TREATMENT OF INFECTION IN ANIMALS |
EP01910035A EP1261259B2 (en) | 2000-03-10 | 2001-03-09 | Treatment of infection in animals |
US10/221,423 US7608291B2 (en) | 2000-03-10 | 2001-03-09 | Treatment of infection in animals |
PCT/GB2001/001036 WO2001065949A1 (en) | 2000-03-10 | 2001-03-09 | Treatment of infection in animals |
AU37617/01A AU779710C (en) | 2000-03-10 | 2001-03-09 | Treatment of infection in animals |
AT01910035T ATE308895T1 (en) | 2000-03-10 | 2001-03-09 | TREATMENT OF INFECTIONS IN ANIMALS |
GB0221446A GB2377638B (en) | 2000-03-10 | 2001-03-09 | Treatment of infection in animals |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9905542.8A GB9905542D0 (en) | 1999-03-10 | 1999-03-10 | Pet food |
GB9905542.8 | 1999-03-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000053030A2 true WO2000053030A2 (en) | 2000-09-14 |
WO2000053030A3 WO2000053030A3 (en) | 2000-12-21 |
Family
ID=10849373
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2000/000890 WO2000053030A2 (en) | 1999-03-10 | 2000-03-10 | Pet food product with coconut endosperm fibre |
Country Status (17)
Country | Link |
---|---|
US (1) | US6656512B1 (en) |
EP (1) | EP1158867B1 (en) |
JP (1) | JP4970656B2 (en) |
CN (1) | CN1345184A (en) |
AT (1) | ATE329494T1 (en) |
AU (1) | AU776479B2 (en) |
BR (1) | BR0008879A (en) |
CA (1) | CA2366920C (en) |
DE (1) | DE60028735T2 (en) |
GB (2) | GB9905542D0 (en) |
HU (1) | HUP0202350A3 (en) |
MX (1) | MXPA01009101A (en) |
NZ (1) | NZ514054A (en) |
PL (1) | PL350537A1 (en) |
RU (1) | RU2269270C2 (en) |
WO (1) | WO2000053030A2 (en) |
ZA (1) | ZA200107322B (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004056198A1 (en) * | 2002-12-23 | 2004-07-08 | Mars Uk Limited | Food for gastrointestinal health |
GB2377638B (en) * | 2000-03-10 | 2004-11-17 | Mars Uk Ltd | Treatment of infection in animals |
JP2005237284A (en) * | 2004-02-26 | 2005-09-08 | Daiwa Fine Products Pte Ltd | Feed for livestock |
EP1684771A1 (en) * | 2003-11-21 | 2006-08-02 | Hill's Pet Nutrition Inc. | Composition and method |
US7160552B2 (en) | 2001-03-09 | 2007-01-09 | Land O'lakes Purina Feed Llc | Method of feeding a ruminant |
US7252836B2 (en) | 2003-01-13 | 2007-08-07 | Penwest, Ltd. | Food and feed compositions including resistant starch |
EP2090179A1 (en) * | 2006-11-21 | 2009-08-19 | Fuji Oil Company, Ltd. | Mannooligosaccharide-containing food composition |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7608291B2 (en) * | 2000-03-10 | 2009-10-27 | Mars, Inc. | Treatment of infection in animals |
MXPA06000693A (en) | 2003-09-05 | 2006-04-11 | Hills Pet Nutrition Inc | Composition for animal consumption. |
US8715717B2 (en) | 2003-09-05 | 2014-05-06 | Hill's Pet Nutrition, Inc. | Composition for animal consumption |
US20050119222A1 (en) | 2003-12-01 | 2005-06-02 | The Iams Company | Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use |
US8685438B2 (en) * | 2004-03-17 | 2014-04-01 | The Iams Company | Compositions, kits, and methods utilizing an added boron source |
JP2006288362A (en) * | 2005-04-08 | 2006-10-26 | Daily Egg:Kk | Feed composition for poultry-farming and hen egg |
EP2056684B1 (en) * | 2006-09-01 | 2010-07-14 | Unilever N.V. | Pre-biotic-containing liquid food product |
US9262818B2 (en) | 2007-05-01 | 2016-02-16 | Pictometry International Corp. | System for detecting image abnormalities |
CN107772343A (en) * | 2017-11-17 | 2018-03-09 | 海南天际食品有限公司 | A kind of coconut powder and preparation method thereof |
CN113412886A (en) * | 2020-12-31 | 2021-09-21 | 江苏翼邦生物技术有限公司 | High-palatability powdery flavoring agent for cats and preparation method and use method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991018521A1 (en) * | 1990-05-29 | 1991-12-12 | Chemgen Corporation | Hemicellulase supplement to improve the energy efficiency of hemicellulose-containing food and animal feed |
JPH08173055A (en) * | 1994-12-21 | 1996-07-09 | Shinichi Hoshida | Mannose-based polysaccharide-containing feed |
WO1996039046A1 (en) * | 1995-06-06 | 1996-12-12 | Mars G.B. Limited | Gelling system comprising carrageenan and coconut endosperm |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5016969A (en) | 1989-08-28 | 1991-05-21 | Raynet Corporation | Mechanism for nesting an optical fiber in an optical coupler and providing positive stop opening and closing positions for the coupler |
JP2887768B2 (en) * | 1991-06-20 | 1999-04-26 | 東和化成工業株式会社 | Animal feed containing calcium and crude fiber |
JPH05255097A (en) * | 1992-01-24 | 1993-10-05 | Miyarisan Seibutsu Igaku Kenkyusho:Kk | Liquid composition |
JPH05238945A (en) * | 1992-02-26 | 1993-09-17 | Eisai Co Ltd | Intestinal environment-improving agent |
AU660862B2 (en) * | 1992-12-22 | 1995-07-06 | Austech Sterile Resource Recovery Pty Ltd | Dehydrated animal feed |
JPH06340863A (en) | 1993-06-01 | 1994-12-13 | Sunstar Eng Inc | Two-pack aqueous adhesive |
JPH0767544A (en) * | 1993-09-03 | 1995-03-14 | Taiyo Kagaku Co Ltd | Feed composition and feed |
JP3054750B2 (en) * | 1994-02-24 | 2000-06-19 | 有限会社生物科学産業研究所 | Manno-oligosaccharide-containing feed |
US5616569A (en) * | 1994-03-28 | 1997-04-01 | The Iams Company | Pet food product containing fermentable fibers and process for treating gastrointestinal disorders |
DK0820306T3 (en) * | 1995-04-03 | 2003-03-10 | Poul Bachmann | Pharmaceutical preparation containing pectin and a phospholipid used as a remedy for diarrhea and gastric ulcer |
JPH1084909A (en) * | 1996-09-13 | 1998-04-07 | Snow Brand Milk Prod Co Ltd | Intestinal butyric acid concentration increase accelerating agent |
JP3720496B2 (en) * | 1996-11-29 | 2005-11-30 | ユニテックフーズ株式会社 | Novel pectin and emulsion containing the same |
CA2268523C (en) * | 1997-08-15 | 2007-01-30 | Unitika Ltd. | Mannose-containing feed and process for producing the same |
-
1999
- 1999-03-10 GB GBGB9905542.8A patent/GB9905542D0/en not_active Ceased
-
2000
- 2000-03-10 DE DE60028735T patent/DE60028735T2/en not_active Expired - Lifetime
- 2000-03-10 EP EP00909476A patent/EP1158867B1/en not_active Expired - Lifetime
- 2000-03-10 AT AT00909476T patent/ATE329494T1/en not_active IP Right Cessation
- 2000-03-10 NZ NZ514054A patent/NZ514054A/en not_active IP Right Cessation
- 2000-03-10 HU HU0202350A patent/HUP0202350A3/en unknown
- 2000-03-10 AU AU31758/00A patent/AU776479B2/en not_active Ceased
- 2000-03-10 JP JP2000603528A patent/JP4970656B2/en not_active Expired - Lifetime
- 2000-03-10 PL PL00350537A patent/PL350537A1/en not_active Application Discontinuation
- 2000-03-10 MX MXPA01009101A patent/MXPA01009101A/en unknown
- 2000-03-10 RU RU2001128222/13A patent/RU2269270C2/en active
- 2000-03-10 CA CA002366920A patent/CA2366920C/en not_active Expired - Fee Related
- 2000-03-10 CN CN00805749A patent/CN1345184A/en active Pending
- 2000-03-10 WO PCT/GB2000/000890 patent/WO2000053030A2/en active IP Right Grant
- 2000-03-10 BR BR0008879-0A patent/BR0008879A/en not_active IP Right Cessation
- 2000-03-10 US US09/936,036 patent/US6656512B1/en not_active Expired - Lifetime
- 2000-03-10 GB GB0121705A patent/GB2363696B/en not_active Expired - Lifetime
-
2001
- 2001-09-04 ZA ZA200107322A patent/ZA200107322B/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991018521A1 (en) * | 1990-05-29 | 1991-12-12 | Chemgen Corporation | Hemicellulase supplement to improve the energy efficiency of hemicellulose-containing food and animal feed |
JPH08173055A (en) * | 1994-12-21 | 1996-07-09 | Shinichi Hoshida | Mannose-based polysaccharide-containing feed |
WO1996039046A1 (en) * | 1995-06-06 | 1996-12-12 | Mars G.B. Limited | Gelling system comprising carrageenan and coconut endosperm |
Non-Patent Citations (2)
Title |
---|
M DIEZ ET AL: "Etude des fibres alimentaires chez le chien: présentation des résultats de 7 essais expérimentaux" ANNALES DES MEDECINE VETERINAIRE,FR,XX, vol. 142, no. 3, 1 January 1998 (1998-01-01), pages 185-198,200-201, XP002093241 * |
PATENT ABSTRACTS OF JAPAN vol. 1996, no. 11, 29 November 1996 (1996-11-29) & JP 08 173055 A (HOSHIDA SHINICHI;SEIBUTSU KAGAKU SANGYO KENKYUSHO:KK; YOUNICHI KAGAKU), 9 July 1996 (1996-07-09) * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2377638B (en) * | 2000-03-10 | 2004-11-17 | Mars Uk Ltd | Treatment of infection in animals |
US7160552B2 (en) | 2001-03-09 | 2007-01-09 | Land O'lakes Purina Feed Llc | Method of feeding a ruminant |
WO2004056198A1 (en) * | 2002-12-23 | 2004-07-08 | Mars Uk Limited | Food for gastrointestinal health |
GB2414916A (en) * | 2002-12-23 | 2005-12-14 | Mars Uk Ltd | Food for gastrointestinal health |
US7252836B2 (en) | 2003-01-13 | 2007-08-07 | Penwest, Ltd. | Food and feed compositions including resistant starch |
EP1684771A1 (en) * | 2003-11-21 | 2006-08-02 | Hill's Pet Nutrition Inc. | Composition and method |
EP1684771B1 (en) * | 2003-11-21 | 2016-08-24 | Hill's Pet Nutrition, Inc. | Composition for treating inflammation of the gastrointestinal tract in pets |
EP3111943A1 (en) * | 2003-11-21 | 2017-01-04 | Hill's Pet Nutrition, Inc. | Composition for treating inflammation of the gastrointestinal tract in pets |
JP2005237284A (en) * | 2004-02-26 | 2005-09-08 | Daiwa Fine Products Pte Ltd | Feed for livestock |
EP2090179A1 (en) * | 2006-11-21 | 2009-08-19 | Fuji Oil Company, Ltd. | Mannooligosaccharide-containing food composition |
EP2090179A4 (en) * | 2006-11-21 | 2012-01-04 | Fuji Oil Co Ltd | Mannooligosaccharide-containing food composition |
Also Published As
Publication number | Publication date |
---|---|
AU3175800A (en) | 2000-09-28 |
HUP0202350A3 (en) | 2002-11-28 |
CA2366920A1 (en) | 2000-09-14 |
US6656512B1 (en) | 2003-12-02 |
HUP0202350A2 (en) | 2002-10-28 |
ATE329494T1 (en) | 2006-07-15 |
ZA200107322B (en) | 2002-12-03 |
MXPA01009101A (en) | 2004-03-26 |
BR0008879A (en) | 2002-01-22 |
DE60028735T2 (en) | 2007-05-24 |
CN1345184A (en) | 2002-04-17 |
JP2002537861A (en) | 2002-11-12 |
JP4970656B2 (en) | 2012-07-11 |
GB2363696A (en) | 2002-01-09 |
EP1158867A2 (en) | 2001-12-05 |
EP1158867B1 (en) | 2006-06-14 |
GB0121705D0 (en) | 2001-10-31 |
CA2366920C (en) | 2008-12-30 |
NZ514054A (en) | 2001-09-28 |
WO2000053030A3 (en) | 2000-12-21 |
RU2269270C2 (en) | 2006-02-10 |
GB2363696B (en) | 2003-07-16 |
AU776479B2 (en) | 2004-09-09 |
PL350537A1 (en) | 2002-12-16 |
DE60028735D1 (en) | 2006-07-27 |
GB9905542D0 (en) | 1999-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
McDonald et al. | Adverse effects of soluble non-starch polysaccharide (guar gum) on piglet growth and experimental colibacillosis immediately after weaning | |
US6656512B1 (en) | Pet food product with coconut endosperm fiber | |
McDonald et al. | Increasing viscosity of the intestinal contents alters small intestinal structure and intestinal growth, and stimulates proliferation of enterotoxigenic Escherichia coli in newly-weaned pigs | |
Twomey et al. | The effects of increasing levels of soluble non-starch polysaccharides and inclusion of feed enzymes in dog diets on faecal quality and digestibility | |
Högberg et al. | Influence of cereal non-starch polysaccharides and enzyme supplementation on digestion site and gut environment in weaned piglets | |
Silvio et al. | Influence of fiber fermentability on nutrient digestion in the dog | |
AU2008229785B2 (en) | Methods and kits related to administration of a fructooligosaccharide | |
Reilly et al. | The effect of cereal-derived beta-glucans and exogenous enzyme supplementation on intestinal microflora, nutrient digestibility, mineral metabolism and volatile fatty acid concentrations in finisher pigs | |
Maria et al. | The effect of age and carbohydrate and protein sources on digestibility, fecal microbiota, fermentation products, fecal IgA, and immunological blood parameters in dogs | |
Atuahene et al. | Value of sheanut cake as a dietary ingredient for broiler chickens | |
Ferreira et al. | In vitro digestion and fermentation characteristics of tropical ingredients, co-products and by-products with potential use in diets for rabbits | |
Pacheco et al. | Citrus pulp and orange fiber as dietary fiber sources for dogs | |
Salem et al. | Influence of aguamiel (Agave atrovirens) as a natural feed additive on cecal fermentation kinetics of some forage species in horse feeding | |
Schwarm et al. | More efficient mastication allows increasing intake without compromising digestibility or necessitating a larger gut: comparative feeding trials in banteng (Bos javanicus) and pygmy hippopotamus (Hexaprotodon liberiensis) | |
US7608291B2 (en) | Treatment of infection in animals | |
Twomey et al. | The replacement value of sorghum and maize with or without supplemental enzymes for rice in extruded dog foods | |
Murray et al. | In vitro fermentation of different ratios of high-temperature dried lucerne and sugar beet pulp incubated with an equine faecal inoculum | |
Millam et al. | Xylanase and glucanase supplementation on growth performance and blood profile of Yankasa rams fed crop residues | |
EP1261259B2 (en) | Treatment of infection in animals | |
O'Shea et al. | The effect of introducing purified β-glucans to a wheat-based diet on total tract digestibility and gaseous manure emissions from pigs as compared with consumption of a β-glucan-rich, barley-based diet | |
Wang et al. | Association of fibre degradation with ruminal dissolved hydrogen in growing beef bulls fed with two types of forages | |
Dado et al. | In vitro ruminal starch digestibility in opaque-2 and regular corn hybrids | |
Kara et al. | The effect of age and processing on the in vitro fermentation of fibrous feedstuffs by labrador retriever dogs | |
Anthonyraj et al. | Chicory root powder included as a prebiotic in different cereal-based diets for dogs: Influences on gut health, metabolic and immunological status | |
Srinivas et al. | Supplementation of tropical red seaweeds improved gut health indices, antioxidant status and immunity in adult dogs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 00805749.4 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001/07322 Country of ref document: ZA Ref document number: 200107322 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000909476 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2366920 Country of ref document: CA Ref document number: 2366920 Country of ref document: CA Kind code of ref document: A Ref document number: 200121705 Country of ref document: GB Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 514054 Country of ref document: NZ Ref document number: 31758/00 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2000 603528 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2001/009101 Country of ref document: MX |
|
WWP | Wipo information: published in national office |
Ref document number: 2000909476 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09936036 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 31758/00 Country of ref document: AU |
|
WWG | Wipo information: grant in national office |
Ref document number: 2000909476 Country of ref document: EP |